| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 617 | 707 | 411 | 209 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit | 617 | 707 | 411 | 209 | | | Operating Expenses | | Research Development | 916 | 1,309 | 935 | 911 | | Selling General and Administrative | 2,202 | 1,691 | 1,509 | 1,879 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,501) | (2,293) | (2,032) | (2,581) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (94) | (18) | 2 | 23 | | Earnings Before Interest And Taxes | (2,595) | (2,311) | (2,031) | (2,559) | | Interest Expense | 263 | 258 | 253 | 215 | | Income Before Tax | (2,858) | (2,569) | (2,283) | (2,774) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,858) | (2,569) | (2,283) | (2,774) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,858) | (2,569) | (2,283) | (2,774) | | Preferred Stock And Other Adjustments | (131) | 44 | (44) | (44) | | | Net Income Applicable To Common Shares | ($2,989) | ($2,525) | ($2,327) | ($2,818) |
|
0.02% Nasdaq 
0.33%
Income Statement
